Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice (Q44474816)

3 December 2017

title

Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice (English)

1 reference

3 December 2017

1 reference

6

1 reference

3 December 2017

John T Fallon

5

0 references

author name string

Reigh-Yi Lin

1

1 reference

3 December 2017

Robin P Choudhury

2

1 reference

3 December 2017

Weijing Cai

3

1 reference

3 December 2017

Min Lu

4

1 reference

3 December 2017

Helen Vlassara

7

1 reference

3 December 2017

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

168

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

213-220

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Advanced glycation end products, oxidant stress and vascular lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Nutritional Consequences of the Maillard Reaction. Amino Acid Availability from Fructose-leucine and Fructose-tryptophan in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Mouse Models of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Standardizing the immunological measurement of advanced glycation endproducts using normal human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)50050-9

10.1016/S0021-9150(03)00050-9

7 January 2021

Identifiers

DOI

1 reference

release_uuu6pkflzjbmfm5joqoserydii

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uuu6pkflzjbmfm5joqoserydii

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference